Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). GNI Group's share price for the quarter that ended in Mar. 2026 was 円2940. GNI Group's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 56 Mil. Therefore, GNI Group's market cap for the quarter that ended in Mar. 2026 was 円163,917 Mil.
GNI Group's quarterly market cap
declined
from Sep. 2025 (円135,318 Mil) to Dec. 2025 (円134,271 Mil) but then
increased
from Dec. 2025 (円134,271 Mil) to Mar. 2026 (円163,917 Mil).
GNI Group's annual market cap
increased
from Dec. 2023 (円141,059 Mil) to Dec. 2024 (円170,778 Mil) but then
declined
from Dec. 2024 (円170,778 Mil) to Dec. 2025 (円134,271 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. GNI Group's Enterprise Value for Today is 円135,296 Mil.
GNI Group (TSE:2160) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
GNI Group Market Cap Related Terms
GNI Group Market Cap Historical Data
* Premium members only.
The historical data trend for GNI Group's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:2160 vs VRTX, REGN, ALNY: Market Cap Comparison
For the Biotechnology subindustry, GNI Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GNI Group Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, GNI Group's Market Cap distribution charts can be found below:
* The bar in red indicates where GNI Group's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
GNI Group's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GNI Group (TSE:2160) has a Market Cap of 円155,609 Mil as of Jul. 01, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on GNI Group and its competitors. According to the industry distribution chart, GNI Group ranks #284 out of 1427 companies in the Biotechnology industry, placing it in the top 19.9%.
Is GNI Group's Market Cap too high?
GNI Group's current Market Cap is 円155,609 Mil. Based on the distribution chart, GNI Group ranks #284 out of 1427 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, GNI Group has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does GNI Group's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, GNI Group ranks #284 out of 1427 companies for Market Cap. This places GNI Group in the top 20% of its industry — outperforming the majority of peers. The industry median Market Cap is 119.57. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 119.57, based on 1,427 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on GNI Group and its competitors. For the Biotechnology industry, the median Market Cap is 119.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GNI Group's current Market Cap is 円155,609 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GNI Group stock overvalued right now?
Based on GuruFocus' analysis, GNI Group (TSE:2160) is currently considered Fairly Valued. The stock's GF Value™ is 円2,780.45, compared to a current price of 円2,791.00 — trading 0.4% above its estimated fair value. The current Market Cap is 円155,609 Mil. GNI Group's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For GNI Group (TSE:2160), the current Market Cap is 円155,609 Mil as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GNI Group (TSE:2160) Overvalued in 2026?
Based on GuruFocus' analysis, GNI Group stock appears to be overvalued.
The current stock price of 円2,791.00 is trading 0.4% above its estimated GF Value™ of 円2,780.45.
GuruFocus considers GNI Group to be Fairly Valued.
Key valuation signals for TSE:2160:
Market Cap: 円155,609 Mil
GF Value™: 円2,780.45 vs. price of 円2,791.00 (0.4% above fair value)
No single metric tells the full story. See the TSE:2160 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.
82GF Score
Get the complete analysis for TSE:2160
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2160 has been successfully added to your 
